ONMD — Onemednet Income Statement
0.000.00%
- $25.57m
- $27.63m
- $1.02m
- 36
- 36
- 17
- 20
Annual income statement for Onemednet, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | 10-K | 10-K | 10-K |
Standards: | — | USG | USG | USG |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 0 | 0 | 1.15 | 1.02 |
Cost of Revenue | ||||
Gross Profit | — | — | -0.361 | -0.128 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | — | 0.585 | 12.6 | 19.9 |
Operating Profit | 0 | -0.585 | -11.4 | -18.9 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | — | 5.14 | -6.01 | -23.2 |
Provision for Income Taxes | ||||
Net Income After Taxes | — | 5.14 | -6.23 | -23.2 |
Net Income Before Extraordinary Items | ||||
Net Income | — | 5.14 | -6.23 | -23.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Dilution Adjustment | ||||
Diluted Net Income | 0 | 5.14 | -6.23 | -23.2 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | — | 0.343 | -0.264 | -0.545 |